Skip to main content

Hemex banks 7.1 million Swiss francs

| News

Hemex banks 7.1 million Swiss francs


Hemex has raised a total of 7.1 million Swiss francs as part of a Series C financing round. The company for clinical contract research and investments in startups intends to finance firms in their early phase in addition to supporting plans aimed at hiring new team members.

Hemex has successfully closed a second tranche of its Series C financing round, further details of which can be found in a press release. In so doing, the company for clinical contract research and investments in startups active in the healthcare industry has so far raised a total of 7.1 million Swiss francs in the year to date.

Hemex, a partner of the investment and innovation promotion agency Basel Area Business & Innovation, intends to use this fresh capital injection to finance initial investments in early-phase startups active in the field of life sciences. Moreover, the company, which is based in Liestal in the canton of Basel-Landschaft, will seek to recruit new team members for clinical activities, quality assurance and regulatory matters.

The support from both existing and new investors “shows the potential of our business model”, comments co-founder and CEO Pascal Winnen in the press release. “With our fast-growing team of highly qualified healthcare professionals as well as a strong network of specialized consultants, we will continue to offer our shareholders the opportunity to identify and invest in early-stage healthcare startups, with active management of the portfolio”, he adds.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.